These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33388573)

  • 1. Evaluation of the molecular detection of ciprofloxacin resistance in Neisseria gonorrhoeae by the ResistancePlus GC assay (SpeeDx).
    Cotton S; McHugh MP; Etherson M; Shepherd J; Templeton KE
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115262. PubMed ID: 33388573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the SpeeDx ResistancePlus® GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae.
    Hadad R; Cole MJ; Ebeyan S; Jacobsson S; Tan LY; Golparian D; Erskine S; Day M; Whiley D; Unemo M;
    J Antimicrob Chemother; 2021 Jan; 76(1):84-90. PubMed ID: 32929456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the ResistancePlus GC (beta) assay: a commercial diagnostic test for the direct detection of ciprofloxacin susceptibility or resistance in Neisseria gonorrhoeae.
    Ebeyan S; Windsor M; Bordin A; Mhango L; Erskine S; Trembizki E; Mokany E; Tan LY; Whiley D;
    J Antimicrob Chemother; 2019 Jul; 74(7):1820-1824. PubMed ID: 30897201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reflex Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae by Use of the SpeeDx ResistancePlus GC Assay.
    Lee DYJ; Ashcroft MM; Chow EPF; Sait M; De Petra V; Tschaepe M; Lange S; Taiaroa G; Bradshaw CS; Whiley DM; Fairley CK; Howden BP; Chen MY; Pasricha S; Williamson DA
    J Clin Microbiol; 2021 Apr; 59(5):. PubMed ID: 33658263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved determination of Neisseria gonorrhoeae gyrase A genotype results in clinical specimens.
    Allan-Blitz LT; Ellis OL; Wee R; Truong A; Ebeyan SM; Tan LY; Mokany E; Flynn R; Klausner JD
    J Antimicrob Chemother; 2019 Oct; 74(10):2913-2915. PubMed ID: 31340021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of molecular ciprofloxacin resistance testing in management of gonorrhoea in a large urban clinic.
    Goldstein E; Moss E; Bennett-Slater S; Ferguson L; McInally C; McHugh M; Maxwell A; Winter A; Gunson RN
    Sex Transm Infect; 2024 May; 100(4):226-230. PubMed ID: 38702191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of Neisseria gonorrhoeae susceptibility to ciprofloxacin in clinical specimens from men using a real-time PCR assay.
    Magooa MP; Müller EE; Gumede L; Lewis DA
    Int J Antimicrob Agents; 2013 Jul; 42(1):63-7. PubMed ID: 23623337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multisite implementation of a real-time polymerase chain reaction assay to predict ciprofloxacin susceptibility in Neisseria gonorrhoeae.
    Ellis O; Hemarajata P; Shahkolahi A; Masinde G; Buchs K; Humphries RM; Klausner JD
    Diagn Microbiol Infect Dis; 2019 Jul; 94(3):213-217. PubMed ID: 30723007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Cas13a-based assays for
    Allan-Blitz L-T; Shah P; Adams G; Branda JA; Klausner JD; Goldstein R; Sabeti PC; Lemieux JE
    mSphere; 2023 Oct; 8(5):e0041623. PubMed ID: 37732792
    [No Abstract]   [Full Text] [Related]  

  • 10. Accurate detection of Neisseria gonorrhoeae ciprofloxacin susceptibility directly from genital and extragenital clinical samples: towards genotype-guided antimicrobial therapy.
    Pond MJ; Hall CL; Miari VF; Cole M; Laing KG; Jagatia H; Harding-Esch E; Monahan IM; Planche T; Hinds J; Ison CA; Chisholm S; Butcher PD; Sadiq ST
    J Antimicrob Chemother; 2016 Apr; 71(4):897-902. PubMed ID: 26817487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wild-Type Gyrase A Genotype of Neisseria gonorrhoeae Predicts In Vitro Susceptibility to Ciprofloxacin: A Systematic Review of the Literature and Meta-Analysis.
    Allan-Blitz LT; Wang X; Klausner JD
    Sex Transm Dis; 2017 May; 44(5):261-265. PubMed ID: 28407640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial susceptibility of Neisseria gonorrhoeae isolated in Bangladesh (1997 to 1999): rapid shift to fluoroquinolone resistance.
    Rahman M; Sultan Z; Monira S; Alam A; Nessa K; Islam S; Nahar S; Shama-A-Waris ; Alam Khan S; Bogaerts J; Islam N; Albert J
    J Clin Microbiol; 2002 Jun; 40(6):2037-40. PubMed ID: 12037060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sharp increase in ciprofloxacin resistance of
    Crucitti T; Belinga S; Fonkoua MC; Abanda M; Mbanzouen W; Sokeng E; Nzouankeu A
    Int J STD AIDS; 2020 May; 31(6):579-586. PubMed ID: 32316853
    [No Abstract]   [Full Text] [Related]  

  • 14. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trend of ciprofloxacin resistance in Neisseria gonorrhoeae strains isolated in Italy and analysis of the molecular determinants.
    Starnino S; Dal Conte I; Matteelli A; Galluppi E; Cusini M; Di Carlo A; Delmonte S; Stefanelli P
    Diagn Microbiol Infect Dis; 2010 Aug; 67(4):350-4. PubMed ID: 20638603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019.
    Aniskevich A; Shimanskaya I; Boiko I; Golubovskaya T; Golparian D; Stanislavova I; Jacobsson S; Adaskevich A; Unemo M
    BMC Infect Dis; 2021 Jun; 21(1):520. PubMed ID: 34078300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
    Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
    BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of ciprofloxacin resistant Neisseria gonorrhoeae in north India.
    Sethi S; Sharma D; Mehta SD; Singh B; Smriti M; Kumar B; Sharma M
    Indian J Med Res; 2006 May; 123(5):707-10. PubMed ID: 16873916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial susceptibility in
    Latif AS; Gwanzura L; Machiha A; Ndowa F; Tarupiwa A; Gudza-Mugabe M; Shukusho FD; Chakanyuka Musanhu C; Wi T; Unemo M
    Sex Transm Infect; 2018 Feb; 94(1):62-66. PubMed ID: 28476914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
    Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
    BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.